Wan Meng, Zhao Dan, Sun Yan, Wang Weihu
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing 100142, China.
J Oncol. 2022 Apr 28;2022:4681794. doi: 10.1155/2022/4681794. eCollection 2022.
We aimed to construct a nomogram for predicting the overall survival (OS) of patients with secondary primary malignancies (SPMs) after hypopharyngeal cancer (HPC).
613 HPC patients were included in the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2018, which were divided into training and validation cohorts. The least absolute shrinkage and selection operation (LASSO) and stepwise Cox regression were used to determine the variables by which a nomogram model was established.
After the LASSO and stepwise Cox regression analysis, the age, year of diagnosis, sites of SPMs, SEER stage of SPMs, surgery for SPMs, and radiotherapy for SPMs were included for model establishment. The ROC curve showed good discrimination for the 3- and 5-year AUC values in the training (0.774 and 0.779, respectively) and validation (0.758 and 0.763, respectively) cohorts. The calibration curve indicated good prognostic accuracy, especially in the 5-year survival prediction for this model. The DCA also demonstrated clinical efficacy over a wide range of threshold probabilities. Lastly, the risk group classified by the individual nomogram values showed significantly different survival outcomes in both training and validation cohorts.
We constructed a nomogram to predict the OS of SPMs after HPC with good clinical values.
我们旨在构建一种列线图,用于预测下咽癌(HPC)后发生继发性原发性恶性肿瘤(SPM)患者的总生存期(OS)。
2000年至2018年间,监测、流行病学和最终结果(SEER)数据库纳入了613例HPC患者,这些患者被分为训练队列和验证队列。采用最小绝对收缩和选择算子(LASSO)及逐步Cox回归来确定用于建立列线图模型的变量。
经过LASSO和逐步Cox回归分析,将年龄、诊断年份、SPM的部位、SPM的SEER分期、SPM的手术治疗以及SPM的放射治疗纳入模型建立。受试者工作特征(ROC)曲线显示,该模型在训练队列(3年和5年曲线下面积[AUC]值分别为0.774和0.779)和验证队列(分别为0.758和0.763)中对3年和5年AUC值具有良好的区分度。校准曲线表明预后准确性良好,尤其是在该模型的5年生存预测方面。决策曲线分析(DCA)也显示在广泛的阈值概率范围内具有临床疗效。最后,根据个体列线图值分类的风险组在训练队列和验证队列中均显示出显著不同的生存结果。
我们构建了一种列线图,用于预测HPC后SPM的OS,具有良好的临床价值。